Terms: = Uterine cancer AND JAK1, ENSG00000162434, P23458, JTK3, JAK1B, JAK1A, 3716
25 results:
1. Listeria-vectored cervical cancer vaccine candidate strains reduce MDSCs via the JAK-STAT signaling pathway.
Zhang Y; Lei Y; Ou Q; Chen M; Tian S; Tang J; Li R; Liang Q; Chen Z; Wang C
BMC Biol; 2024 Apr; 22(1):88. PubMed ID: 38641823
[TBL] [Abstract] [Full Text] [Related]
2. CD146
Yu Z; Zhang Q; Wei S; Zhang Y; Zhou T; Zhang Q; Shi R; Zinovkin D; Pranjol ZI; Zhang J; Wang H
Cell Commun Signal; 2024 Mar; 22(1):170. PubMed ID: 38459564
[TBL] [Abstract] [Full Text] [Related]
3. Risk stratification and molecular heterogeneity of endometrial cancer and expression profile of TIM-3: A retrospective cohort study.
Zhang Y; Yang R; Xu C; Zhang Y; Deng M; Wu D; Tang F; Liu X; Han Y; Zhan Y; Miao J
Gynecol Oncol; 2023 Mar; 170():210-220. PubMed ID: 36709662
[TBL] [Abstract] [Full Text] [Related]
4. jak1 inactivation promotes proliferation and migration of endometrial cancer cells via upregulating the hypoxia-inducible factor signaling pathway.
Lin Q; Chen Z; Shi W; Lv Z; Wan X; Gao K
Cell Commun Signal; 2022 Nov; 20(1):177. PubMed ID: 36376931
[TBL] [Abstract] [Full Text] [Related]
5. Distinct Mechanisms of Mismatch-Repair Deficiency Delineate Two Modes of Response to Anti-PD-1 Immunotherapy in Endometrial Carcinoma.
Chow RD; Michaels T; Bellone S; Hartwich TMP; Bonazzoli E; Iwasaki A; Song E; Santin AD
Cancer Discov; 2023 Feb; 13(2):312-331. PubMed ID: 36301137
[TBL] [Abstract] [Full Text] [Related]
6. Synergistic effects of thalidomide and cisplatin are mediated via the PI3K/AKT and jak1/STAT3 signaling pathways in cervical cancer.
Liu C; Feng H; Song L; Li S; Wu Y; Yang L
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 35920185
[TBL] [Abstract] [Full Text] [Related]
7. Microsatellite Instability-High Endometrial cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles.
Manning-Geist BL; Liu YL; Devereaux KA; Paula ADC; Zhou QC; Ma W; Selenica P; Ceyhan-Birsoy O; Moukarzel LA; Hoang T; Gordhandas S; Rubinstein MM; Friedman CF; Aghajanian C; Abu-Rustum NR; Stadler ZK; Reis-Filho JS; Iasonos A; Zamarin D; Ellenson LH; Lakhman Y; Mandelker DL; Weigelt B
Clin Cancer Res; 2022 Oct; 28(19):4302-4311. PubMed ID: 35849120
[TBL] [Abstract] [Full Text] [Related]
8. Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape.
Glaire MA; Ryan NA; Ijsselsteijn ME; Kedzierska K; Obolenski S; Ali R; Crosbie EJ; Bosse T; de Miranda NF; Church DN
J Pathol; 2022 Jul; 257(3):340-351. PubMed ID: 35262923
[TBL] [Abstract] [Full Text] [Related]
9. The anti-neoplastic activities of aloperine in HeLa cervical cancer cells are associated with inhibition of the IL-6-jak1-STAT3 feedback loop.
Chen YD; Cai FY; Mao YZ; Yang YS; Xu K; Liu XF; Fan WW; Chen W; Jiang FQ; Zhang H
Chin J Nat Med; 2021 Nov; 19(11):815-824. PubMed ID: 34844720
[TBL] [Abstract] [Full Text] [Related]
10. Formononetin represses cervical tumorigenesis by interfering with the activation of PD-L1 through MYC and STAT3 downregulation.
Wang JY; Jiang MW; Li MY; Zhang ZH; Xing Y; Ri M; Jin CH; Xu GH; Piao LX; Jin HL; Ma J; Jin Y; Zuo HX; Jin X
J Nutr Biochem; 2022 Feb; 100():108899. PubMed ID: 34748924
[TBL] [Abstract] [Full Text] [Related]
11. Lycorine inhibits cell proliferation and induced oxidative stress-mediated apoptosis via regulation of the JAK/STAT3 signaling pathway in HT-3 cells.
Shang H; Jang X; Shi L; Ma Y
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22882. PubMed ID: 34558146
[TBL] [Abstract] [Full Text] [Related]
12. Basaloid Squamous Cell Carcinoma of the uterine Cervix: Report of a Case With Molecular Analysis.
Munkhdelger J; Shimooka T; Koyama Y; Ikeda S; Mikami Y; Fukuoka J; Hori T; Bychkov A
Int J Surg Pathol; 2021 Oct; 29(7):770-774. PubMed ID: 33792431
[TBL] [Abstract] [Full Text] [Related]
13. Combined inhibition of jak1/2 and DNMT1 by newly identified small-molecule compounds synergistically suppresses the survival and proliferation of cervical cancer cells.
She S; Zhao Y; Kang B; Chen C; Chen X; Zhang X; Chen W; Dan S; Wang H; Wang YJ; Zhao J
Cell Death Dis; 2020 Sep; 11(9):724. PubMed ID: 32895373
[TBL] [Abstract] [Full Text] [Related]
14. Gene Expression Analysis Identifies Novel Targets for Cervical cancer Therapy.
Roszik J; Ring KL; Wani KM; Lazar AJ; Yemelyanova AV; Soliman PT; Frumovitz M; Jazaeri AA
Front Immunol; 2018; 9():2102. PubMed ID: 30283446
[TBL] [Abstract] [Full Text] [Related]
15. Myometrium Invasion, Tumour Size and Lymphovascular Invasion as a Prognostic Factor in Dissemination of Pelvic Lymphatics at Endometrial Carcinoma.
Lucic N; Draganovic D; Sibincic S; Ecim-Zlojutro V; Milicevic S
Med Arch; 2017 Oct; 71(5):325-329. PubMed ID: 29284899
[TBL] [Abstract] [Full Text] [Related]
16. Molecular Pathology and Novel Clinical Therapy for uterine Leiomyosarcoma.
Hayashi T; Kawano M; Ichimura T; Ida K; Ando H; Zharhary D; Kanai Y; Aburatani H; Tonegawa S; Shiozawa T; Yaegashi N; Konishi I
Anticancer Res; 2016 Oct; 36(10):4997-5007. PubMed ID: 27798858
[TBL] [Abstract] [Full Text] [Related]
17. Microsatellite instability derived jak1 frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer.
Stelloo E; Versluis MA; Nijman HW; de Bruyn M; Plat A; Osse EM; van Dijk RH; Nout RA; Creutzberg CL; de Bock GH; Smit VT; Bosse T; Hollema H
Oncotarget; 2016 Jun; 7(26):39885-39893. PubMed ID: 27213585
[TBL] [Abstract] [Full Text] [Related]
18. IL6/jak1/STAT3 Signaling Blockade in Endometrial cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden.
van der Zee M; Sacchetti A; Cansoy M; Joosten R; Teeuwssen M; Heijmans-Antonissen C; Ewing-Graham PC; Burger CW; Blok LJ; Fodde R
Cancer Res; 2015 Sep; 75(17):3608-22. PubMed ID: 26130650
[TBL] [Abstract] [Full Text] [Related]
19. Blockage of PTPRJ promotes cell growth and resistance to 5-FU through activation of jak1/STAT3 in the cervical carcinoma cell line C33A.
Yan CM; Zhao YL; Cai HY; Miao GY; Ma W
Oncol Rep; 2015 Apr; 33(4):1737-44. PubMed ID: 25634668
[TBL] [Abstract] [Full Text] [Related]
20. Polymorphisms in immune mediators associate with risk of cervical cancer.
Zhang Z; Fye S; Borecki IB; Rader JS
Gynecol Oncol; 2014 Oct; 135(1):69-73. PubMed ID: 25127987
[TBL] [Abstract] [Full Text] [Related]
[Next]
